-+ 0.00%
-+ 0.00%
-+ 0.00%

Macquarie Maintains Outperform on Imax, Raises Price Target to $44

Benzinga·01/15/2026 20:41:03
Listen to the news
Macquarie analyst Chad Beynon maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $39 to $44.